In 2023, Italy led European Business Expenditure on R&D in Human Health Activities with 314.44 million euros, followed by Spain at 295.94 million euros and Sweden at 192.62 million euros. Hungary, Portugal, and Finland had moderate spending, while Slovakia, Croatia, Czech Republic, and Malta recorded low R&D investments. Year-on-year change reveals Finland saw a noticeable increase of 28.82%, and Slovakia surged by 44.62%, whereas the Czech Republic experienced a decline of 11.4%.
In the future, attention should be on countries with existing low R&D investment, particularly those showing significant percentage increases, suggesting potential rapid expansion and growth in their human health research initiatives.
Top countries in Business Expenditure on R&D in Human Health Activities by Country
| # | 10 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 314.44 | 2023 | +5.78% | +3.56% | View data |
| 2 | 2 Spain | 295.94 | 2021 | View data | ||
| 3 | 3 Sweden | 192.62 | 2023 | +23.4% | View data | |
| 4 | 4 Hungary | 48.32 | 2021 | View data | ||
| 5 | 5 Portugal | 47.04 | 2023 | +6.44% | +19.23% | View data |
| 6 | 6 Finland | 46.83 | 2023 | +18.11% | +28.82% | View data |
| 7 | 7 Slovakia | 17.76 | 2023 | +8.36% | +44.62% | View data |
| 8 | 8 Croatia | 16.23 | 2023 | +44.31% | View data | |
| 9 | 9 Czech Republic | 1.63 | 2023 | -13.02% | -11.4% | View data |
| 10 | 10 Malta | 0.52 | 2023 | +6.85% | View data |
